References
- Ali-Boucetta H, Al-Jamal KT, McCarthy D, et al. (2008). Multiwalled carbon nanotube--doxorubicin supramolecular complexes for cancer therapeutics. Chem Commun 4:459--61
- Belyanskaya L, Manser P, Spohn P, et al. (2007). The reliability and limits of the MTT reduction assay for carbon nanotubes–cell interaction. Carbon 45:2643–8
- Bianco A, Kostarelos K, Prato M. (2005). Applications of carbon nanotubes in drug delivery. Curr Opin Chem Biol 9:674–9
- Chourasia M, Jain S. (2004). Design and development of multiparticulate system for targeted drug delivery to colon. Drug Deliv 11:201--7
- Jose S, Dhanya K, Cinu T, et al. (2009). Colon targeted drug delivery: different approaches. J Young Pharm 1:13--19
- Kam NWS, Jessop TC, Wender PA, et al. (2004). Nanotube molecular transporters: internalization of carbon nanotube-protein conjugates into mammalian cells. J Am Chem Soc 126:6850–1
- Lay CL, Liu HQ, Tan HR, et al. (2010). Delivery of paclitaxel by physically loading onto poly (ethylene glycol)(PEG)-graftcarbon nanotubes for potent cancer therapeutics. Nanotechnology 21:5101--4
- Li P, Wang Y, Chen L, et al. (2011). Synthesis and characterization of folate conjugated chitosan and cellular uptake of its nanoparticles in HT-29. Carbohyd Res 346:801–6
- Liu Z, Davis C, Cai W, et al. (2008). Circulation and long-term fate of functionalized, biocompatible single-walled carbon nanotubes in mice probed by Raman spectroscopy. Proc Natl Acad Sci USA 105:1410–15
- Lorenzo-Lamosa M, Remunan-Lopez C, Vila-Jato J, et al. (1998). Design of microencapsulated chitosan microspheres for colonic drug delivery. J Control Release 52:109–18
- Paharia A, Yadav AK, Rai G, et al. (2007). Eudragit-coated pectin microspheres of 5-fluorouracil for colon targeting. AAPS PharmSciTech 8:87--93
- Patel HK, Nagle A, Murthy R. (2008). Characterization of calcium alginate beads of 5-fluorouracil for colon delivery. Asian J Pharmaceut 2:241–5
- Peng Z, Feng C, Luo Y, et al. (2010). Self-assembled natural rubber/multi-walled carbon nanotube composites using latex compounding techniques. Carbon 48:4497–503
- Peppas N. (1985). Analysis of Fickian and non-Fickian drug release from polymers. Pharmaceut Acta Helvet 60:110–11
- Philip AK, Philip B. (2010). Colon targeted drug delivery systems: a review on primary and novel approaches. Oman Med J 25:79--87
- Rodríguez M, Vila-Jato JL, Torres D. (1998). Design of a new multiparticulate system for potential site-specific and controlled drug delivery to the colonic region. J Control Release 55:67--77
- Sayes CM, Liang F, Hudson JL. (2006). Functionalization density dependence of single-walled carbon nanotubes cytotoxicity in vitro. Toxicol Lett 161:135--42
- Shivani N, Hetal P, Rajesh K, et al. (2011). Colon delivery of 5-fluoro uracil using cross-linked chitosan microspheres coated with eudragit S 100. Int J Drug Deliv 3:260–8
- Siegel R, Ward E, Brawley O, et al. (2011). Cancer statistics, 2011. CA: Cancer J Clinicians 61:212–36
- Thakral NK, Ray AR, Majumdar DK. (2010). Eudragit S-100 entrapped chitosan microspheres of valdecoxib for colon cancer. J Mater Sci-Mater Med 21:2691–9
- Vanhoefer U, Harstrick A, Achterrath W, et al. (2001). Irinotecan in the treatment of colorectal cancer: clinical overview. J Clin Oncol 19:1501–18
- Yang L, Chu JS, Fix JA. (2002). Colon-specific drug delivery: new approaches and in vitro/in vivo evaluation. Int J Pharm 235:1--15
- Zhang H, Alsarra IA, Neau SH. (2002). An in vitro evaluation of a chitosan-containing multiparticulate system for macromolecule delivery to the colon. Int J Pharmaceut 239:197–205
- Zhang J, Misra RDK. (2007). Magnetic drug-targeting carrier encapsulated with thermosensitive smart polymer: core–shell nanoparticle carrier and drug release response. Acta Biomater 3:838–50